FDA warning for alternative health to treat Lyme disease.

[Guest guest]

MedWatch - The FDA Safety Information and Adverse Event Reporting

Program

FDA notified healthcare professionals and consumers not to use an

injectable product called Bismacine, also known as Chromacine.

Bismacine is not a pharmaceutical and has not been approved to treat

any

condition, however, it is being prescribed or administered by

doctors of

" alternative health " to treat Lyme disease.

This product contains high amounts of bismuth, a heavy metal that is

used in some medications taken by mouth to treat Helicobacter

pylori, a

bacteria that can cause stomach ulcers. Bismacine is not approved in

any form for use by injection.

The FDA is investigating one report of death and several reports of

injury related to the administration of Bismacine. Individuals who

believe they have suffered adverse events from receiving Bismacine

should seek medical attention. Possible effects of bismuth poisoning

include cardio-vascular collapse and kidney failure.

Read the complete MedWatch 2006 Safety summary, including links to

the

FDA Press Release at:

http://www.fda.gov/medwatch/safety/2006/safety06.htm#Bismacine